17-27774211-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000625.4(NOS2):​c.1476+46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 1,366,358 control chromosomes in the GnomAD database, including 33,411 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.20 ( 3124 hom., cov: 32)
Exomes 𝑓: 0.22 ( 30287 hom. )

Consequence

NOS2
NM_000625.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.961

Publications

11 publications found
Variant links:
Genes affected
NOS2 (HGNC:7873): (nitric oxide synthase 2) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
NOS2 Gene-Disease associations (from GenCC):
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 17-27774211-G-A is Benign according to our data. Variant chr17-27774211-G-A is described in ClinVar as Benign. ClinVar VariationId is 2688145.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.278 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOS2NM_000625.4 linkc.1476+46C>T intron_variant Intron 12 of 26 ENST00000313735.11 NP_000616.3 P35228-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOS2ENST00000313735.11 linkc.1476+46C>T intron_variant Intron 12 of 26 1 NM_000625.4 ENSP00000327251.6 P35228-1

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29929
AN:
151696
Hom.:
3125
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.129
Gnomad AMR
AF:
0.274
Gnomad ASJ
AF:
0.169
Gnomad EAS
AF:
0.291
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.253
Gnomad NFE
AF:
0.216
Gnomad OTH
AF:
0.213
GnomAD2 exomes
AF:
0.214
AC:
26684
AN:
124684
AF XY:
0.214
show subpopulations
Gnomad AFR exome
AF:
0.122
Gnomad AMR exome
AF:
0.297
Gnomad ASJ exome
AF:
0.173
Gnomad EAS exome
AF:
0.293
Gnomad FIN exome
AF:
0.182
Gnomad NFE exome
AF:
0.207
Gnomad OTH exome
AF:
0.203
GnomAD4 exome
AF:
0.221
AC:
268520
AN:
1214544
Hom.:
30287
Cov.:
18
AF XY:
0.222
AC XY:
131494
AN XY:
593072
show subpopulations
African (AFR)
AF:
0.123
AC:
3147
AN:
25504
American (AMR)
AF:
0.294
AC:
5841
AN:
19876
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
3108
AN:
17596
East Asian (EAS)
AF:
0.354
AC:
11170
AN:
31546
South Asian (SAS)
AF:
0.264
AC:
13756
AN:
52018
European-Finnish (FIN)
AF:
0.184
AC:
8645
AN:
47054
Middle Eastern (MID)
AF:
0.269
AC:
1186
AN:
4410
European-Non Finnish (NFE)
AF:
0.218
AC:
210612
AN:
966776
Other (OTH)
AF:
0.222
AC:
11055
AN:
49764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
9892
19784
29676
39568
49460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7816
15632
23448
31264
39080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.197
AC:
29938
AN:
151814
Hom.:
3124
Cov.:
32
AF XY:
0.198
AC XY:
14684
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.127
AC:
5257
AN:
41396
American (AMR)
AF:
0.274
AC:
4179
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.169
AC:
586
AN:
3464
East Asian (EAS)
AF:
0.291
AC:
1493
AN:
5138
South Asian (SAS)
AF:
0.264
AC:
1267
AN:
4800
European-Finnish (FIN)
AF:
0.178
AC:
1876
AN:
10530
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.216
AC:
14642
AN:
67924
Other (OTH)
AF:
0.211
AC:
444
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1188
2375
3563
4750
5938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.173
Hom.:
681
Bravo
AF:
0.198
Asia WGS
AF:
0.255
AC:
890
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied by a panel of primary immunodeficiencies. Number of patients: 43. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.24
DANN
Benign
0.67
PhyloP100
-0.96
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3729966; hg19: chr17-26101237; COSMIC: COSV58225806; API